Advertisement

Topics

Venture Funding Deals: From ADC To Y-mAbs, Capital Flows For New Platforms, Novel Approaches

11:20 EST 10 Nov 2017 | SCRIP

October was an active fundraising month for both start-up biopharma companies and more established privately held firms, ranging from $3m...

      

Related Stories

 

Original Article: Venture Funding Deals: From ADC To Y-mAbs, Capital Flows For New Platforms, Novel Approaches

NEXT ARTICLE

More From BioPortfolio on "Venture Funding Deals: From ADC To Y-mAbs, Capital Flows For New Platforms, Novel Approaches"

Advertisement
Quick Search
Advertisement
Advertisement